Letter from the CEO

Dear Visitor,

I would like to welcome you to the website of ACROVIS biostructures, a biopharmaceutical company headquartered in Ulm, Germany.
Ulm –city of Albert Einstein`s birth- has a long tradition in science, innovations and inventions.

Following these traditions, we at ACROVIS are seeking to set new standards in the development of preclinical drug candidates. Besides our proprietary in-house therapeutic programs in the fields of chronic liver diseases and cancer, we built up a successful fee-for-service contract research business offering integrated and comprehensive services for structure-based drug discovery. ACROVIS has the expertise to successfully develop new preclinical drug candidates.

In the last decade, structure-based drug design has become an integral part of drug discovery. Our integrated structure-based drug development platforms speed drug discovery and cut development costs by helping our chemists to narrow down molecule choices, to find a needle in a haystack.

It is clear that targeted strategies to find new medicines are a successful approach that will increasingly be saving lives every day.

Thank you for your interest in ACROVIS and for visiting our website. I hope you find it informative. If you have any questions about ACROVIS and how we can assist you in achieving your company’s objectives, please do not hesitate to contact us. We welcome the opportunity to speak with you and to contribute to your success.

Sincerely,

Dr. Thomas Haehner
Chief Executive Officer